Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2023 ∙ Jennings, S. Corrin, T. Waddell, L.

A systematic review of the evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Allison, L. E. Alhaffar, M. Checchi, F. Abdelmagid, N. Nor, B. Sabahelzain, M. M. Light, P. M. Singh, N. S.

A Systematic Review of Vaccination Guidance for Humanitarian Responses

  • All age groups
  • Pregnant women
  • Yellow fever
  • Cholera
  • Meningococcal disease
  • Hepatitis A
  • Varicella
  • Human papillomavirus (HPV)
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Ayyalasomayajula, S. Dhawan, A. Karattuthodi, M. S. Thorakkattil, S. A. Abdulsalim, S. Elnaem, M. H. Sridhar, S. Unnikrishnan, M. K.

A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.

A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia

  • Eastern Mediterranean
  • Saudi Arabia
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Muwanda, F. Sendagire, H. Mboowa, G. Kateete, D. P. Achan, B. Mupere, E. Kafeero, H. M. Bagaya, B. S.

A systematic review reveals that African children of 15-17 years demonstrate low hepatitis B vaccine seroprotection rates

  • Africa
  • Adolescents
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Segal, H. A. Rashid, N.

A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Fasce, A. Schmid, P. Holford, D. L. Bates, L. Gurevych, I. Lewandowsky, S.

A taxonomy of anti-vaccination arguments from a systematic literature review and text modelling

  • All age groups
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis

  • South-East Asia
  • India
  • All age groups
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Derbie, A. Mekonnen, D. Misgan, E. Maier, M. Woldeamanuel, Y. Abebe, T.

Acceptance of human papillomavirus vaccination and parents’ willingness to vaccinate their adolescents in Ethiopia: a systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Parents/caregivers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen

Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Pneumococcal disease
  • Rotavirus
  • Human papillomavirus (HPV)
  • Meningococcal disease
  • Mumps
  • Measles
  • Rubella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...